134 related articles for article (PubMed ID: 8405027)
1. The extrapulmonary effects of inhaled hexoprenaline and salbutamol in healthy individuals.
Bremner P; Burgess C; Purdie G; Beasley R; Crane J
Eur J Clin Pharmacol; 1993; 45(1):37-9. PubMed ID: 8405027
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline.
Crane J; Burgess C; Beasley R
Thorax; 1989 Feb; 44(2):136-40. PubMed ID: 2928998
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the cardiovascular and metabolic effects of formoterol, salbutamol and fenoterol.
Bremner P; Woodman K; Burgess C; Crane J; Purdie G; Pearce N; Beasley R
Eur Respir J; 1993 Feb; 6(2):204-10. PubMed ID: 8095240
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the haemodynamic and hypokalaemic effects of inhaled pirbuterol and salbutamol.
Windom H; Grainger J; Burgess C; Crane J; Pearce N; Beasley R
N Z Med J; 1990 Jun; 103(891):259-61. PubMed ID: 1972557
[TBL] [Abstract][Full Text] [Related]
5. Time course and relative dose potency of systemic effects from salmeterol and salbutamol in healthy subjects.
Bennett JA; Tattersfield AE
Thorax; 1997 May; 52(5):458-64. PubMed ID: 9176539
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and extrapulmonary beta 2 adrenoceptor activity of nebulised racemic salbutamol and its R and S isomers in healthy volunteers.
Lipworth BJ; Clark DJ; Koch P; Arbeeny C
Thorax; 1997 Oct; 52(10):849-52. PubMed ID: 9404370
[TBL] [Abstract][Full Text] [Related]
7. Short-term effects of inhaled salbutamol on autonomic cardiovascular control in healthy subjects: a placebo-controlled study.
Cekici L; Valipour A; Kohansal R; Burghuber OC
Br J Clin Pharmacol; 2009 Apr; 67(4):394-402. PubMed ID: 19371312
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the uterine beta2-adrenoreceptor selectivity of fenoterol, hexoprenaline, ritodrine and salbutamol.
Lipshitz J; Baillie P; Davey DA
S Afr Med J; 1976 Nov; 50(49):1969-72. PubMed ID: 1013850
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the extrapulmonary beta2-adrenoceptor responses and pharmacokinetics of salbutamol given by standard metered dose-inhaler and modified actuator device.
Newnham DM; McDevitt DG; Lipworth BJ
Br J Clin Pharmacol; 1993 Nov; 36(5):445-50. PubMed ID: 12959292
[TBL] [Abstract][Full Text] [Related]
10. Partial vs full beta-receptor agonism. A clinical study of inhaled albuterol and fenoterol.
Bremner P; Siebers R; Crane J; Beasley R; Burgess C
Chest; 1996 Apr; 109(4):957-62. PubMed ID: 8635377
[TBL] [Abstract][Full Text] [Related]
11. The pulmonary and extra-pulmonary effects of high-dose formoterol in COPD: a comparison with salbutamol.
Goldkorn A; Diotto P; Burgess C; Weatherall M; Holt S; Beasley R; Siebers R
Respirology; 2004 Mar; 9(1):102-8. PubMed ID: 14982610
[TBL] [Abstract][Full Text] [Related]
12. Comparison of hypokalaemic, electrocardiographic and haemodynamic responses to inhaled isoprenaline and salbutamol in young and elderly subjects.
Lipworth BJ; Tregaskis BF; McDevitt DG
Eur J Clin Pharmacol; 1991; 40(3):255-60. PubMed ID: 2060561
[TBL] [Abstract][Full Text] [Related]
13. Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers.
Scheinin M; Koulu M; Laurikainen E; Allonen H
Br J Clin Pharmacol; 1987 Nov; 24(5):645-53. PubMed ID: 2829953
[TBL] [Abstract][Full Text] [Related]
14. Nebulized fenoterol causes greater cardiovascular and hypokalaemic effects than equivalent bronchodilator doses of salbutamol in asthmatics.
Bremner P; Burgess C; Beasley R; Woodman K; Marshall S; Crane J; Pearce N
Respir Med; 1992 Sep; 86(5):419-23. PubMed ID: 1462021
[TBL] [Abstract][Full Text] [Related]
15. Does tachyphylaxis occur to the non-pulmonary effects of salmeterol?
Maconochie JG; Minton NA; Chilton JE; Keene ON
Br J Clin Pharmacol; 1994 Feb; 37(2):199-204. PubMed ID: 7910472
[TBL] [Abstract][Full Text] [Related]
16. Single dosing comparison of the relative cardiac beta 1/beta 2 activity of inhaled fenoterol and salbutamol in normal subjects.
Newnham DM; Wheeldon NM; Lipworth BJ; McDevitt DG
Thorax; 1993 Jun; 48(6):656-8. PubMed ID: 8102213
[TBL] [Abstract][Full Text] [Related]
17. The acute effects of inhaled salbutamol on the beat-to-beat variability of heart rate and blood pressure assessed by spectral analysis.
Jartti T; Kaila T; Tahvanainen K; Kuusela T; Vanto T; Välimäki I
Br J Clin Pharmacol; 1997 Apr; 43(4):421-8. PubMed ID: 9146855
[TBL] [Abstract][Full Text] [Related]
18. Systemic beta-adrenoceptor responses to salbutamol given by metered-dose inhaler alone and with pear shaped spacer attachment: comparison of electrocardiographic, hypokalaemic and haemodynamic effects.
Lipworth BJ; McDevitt DG; Struthers AD
Br J Clin Pharmacol; 1989 Jun; 27(6):837-42. PubMed ID: 2547409
[TBL] [Abstract][Full Text] [Related]
19. Lung delivery of non-CFC salbutamol via small volume metal spacer and large volume plastic spacer devices compared with an open vent jet nebulizer.
Lipworth BJ; Clark DJ
Br J Clin Pharmacol; 1998 Feb; 45(2):160-3. PubMed ID: 9491830
[TBL] [Abstract][Full Text] [Related]
20. Salbutamol metered-dose inhaler with spacer for hyperkalemia: how fast? How safe?
Mandelberg A; Krupnik Z; Houri S; Smetana S; Gilad E; Matas Z; Priel IE
Chest; 1999 Mar; 115(3):617-22. PubMed ID: 10084465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
